Yüklüyor......
Observations following discontinuation of long-term denosumab therapy
SUMMARY: Stopping denosumab after 8 years of continued treatment was associated with bone loss during a 1-year observation study in patients who were not prescribed osteoporosis treatment. Bone loss was attenuated in patients who began another osteoporosis therapy. Treatment to prevent bone loss upo...
Kaydedildi:
| Yayımlandı: | Osteoporos Int |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer London
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5391373/ https://ncbi.nlm.nih.gov/pubmed/28144701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-017-3919-1 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|